Peter Mezes Thanks Thrombosis UK and North Bristol NHS Trust for The Support
Peter Mezes, Consultant Vascular and Interventional Radiologist at North Bristol NHS Trust, reposted from North Bristol NHS Trust on LinkedIn:
”Very proud to be part of and work with this fantastic team every day.
Big thanks to Thrombosis UK for recognizing and to North Bristol NHS Trust for supporting the service.”
Quoting North Bristol NHS Trust‘s post:
”World Thrombosis Day
To celebrate World Thrombosis Day we’re highlighting our Pulmonary Embolism Response Team (PERT), formed in 2023 and this years winner of a Thrombosis UK VTE Award for Quality Improvement Programme Advancing Practice in Thrombosis Prevention and Management.
Audit data from 2022 showed up to 10% of NBT patients with intermediate‑high risk Pulmonary Embolism died; PERT helps identify those who may benefit from mechanical thrombectomy, a minimally invasive catheter procedure to remove the clot.
The team has grown from 3 to over 20 clinicians and AHPs, is activated two to three times a month, and is improving care and outcomes across the region.
Congratulations to the team and thank you to Thrombosis UK, registered charity.”
Stay updated with Hemostasis Today.
-
Sep 11, 2026, 03:10Chris Oung: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
-
Sep 10, 2026, 21:33J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD
-
Sep 10, 2026, 21:31Alejandro González Veliz: Pregnancy is a Cardiovascular Stress Test
-
Sep 10, 2026, 21:30Tareq Abadl: Did You Know That the Type of Hemoglobin in Our Blood Changes Throughout Life?
-
Sep 10, 2026, 21:30Sumyea Kabir: Apheresis Awareness Day – One Donor, One Procedure, One Therapeutic Difference
-
Sep 10, 2026, 21:30Suhasini Sil: Excited to Share Our New Publication on HLA Beyond Histocompatibility
-
Sep 10, 2026, 21:29Michael Meneghini: Your Calves Are Not Just for Walking
-
Sep 10, 2026, 21:27One month until International Plasma Awareness Week – PPTA Europe
-
Sep 10, 2026, 21:26John Strouse: Supporting Research to Improve Lives in Sickle Cell Disease